Joseph Cebollero Email & Phone Number

White Plains, New York, United States

Finished 2023 Ranked 12th out of 130 Nationally, top 9%.

New York City Metropolitan Area

Newburgh, New York, United States

Ranked 3rd in Region for Q4 2021 Farxiga Goal. Circle of Excellence Award, 2018 ( ranked 10/201)Expand utilization and growing reputation of Farxiga and Brillinta through appropriate extension of use in CHF and Acute Coronary Syndrome population. Exceeded all sales goals even with highest market share regionally distributed by location. Grew Brilinta NRx 350% between 2016 and 2018.District Clinical Trial Presentation Trainer – focus on the presentation, understanding and analysis of new trials for the purpose of scientific exchanges with customers consistent with drug indications.

White Plains/ Bronx New York, United States

Circle of Excellence Award winner, 2016 (ranked 2/ 98)“Sales Excellence Award” Nominee, 2015 Worked collaboratively as HOSPITAL point person with overlapping primary care and specialty sales representatives for Crestor, Seroquel and Seroquel XR, Symbicort, Atacand, Toprol XL, Zestril, the carbapenem, Merrem, and intravenous Nexium. Began managing Brillinta solely in 2011. Primary accounts – MONTEFIORE MEDICAL CENTER, their affiliated hospitals and JACOBI MEDICAL CENTER Selected as delegate for American Congress of Cardiology National Society Meeting, 2015 2011-2016, achieved 12 Brillinta and 3 Crestor formulary wins in 13 hospitals 2005-2010, achieved 35 formulary wins across 11 hospitals for Nexium IV, Seroquel XR, Symbicort and Crestor

Bronx, New York, United States

Circle of Excellence Winner, 2002 (top 5%) Territory lead for cardiologists in a team of 10 sales representatives responsible for Atacand, Zestril, Toprol, and Crestor. Identify and cultivate local KOL’s (Key Opinion Leaders) to lecture at regional and national programs. Exhibit medication portfolio at annual National Society Meetings. 2005, promotion to newly created Hospital Division